lilly glp 1 pill Eli GLP-1 Foundayo approved for obesity Why Foundayo, the new once-daily

DTC portals for drugs are a solution to a problem that wouldnt exist if insurer coverage were better

Stay on Track

Shares of Eli Lilly and Company (NYSE:LLY) slipped around 2% after the latest weekly prescription data pointed to mixed trends across its GLP-1 drug portfolio

Medications like semaglutide, tirzepatide, liraglutide, and others are defined as GLP-1 meds, and they've revolutionized weight reduction

Within months of GLP-1 prescriptions written for obesity and overweight, JP Morgan analysts wrote an influential report on the drug category and implications for the health care industryand other sectors, notably food and beverage consumption